3349 — Cosmos Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedLarge CapNeutral

Annual balance sheet for Cosmos Pharmaceutical, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.

	2021 May 31st	2022 May 31st	2023 May 31st	2024 May 31st	2025 May 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	—	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	55,108	37,362	45,928	52,301	57,038
Net Total Accounts Receivable
Net Total Receivables	6,619	8,577	10,221	12,199	12,240
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	125,125	115,471	137,085	154,333	165,622
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	195,131	225,286	259,464	295,798	331,125
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	341,318	363,052	420,967	476,546	524,755
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	159,537	162,063	192,053	213,229	220,680
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	170,740	172,545	209,895	245,104	267,292
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	170,578	190,507	211,072	231,442	257,463
Total Liabilities & Shareholders' Equity	341,318	363,052	420,967	476,546	524,755
Total Common Shares Outstanding